Sumitomo Mitsui Trust Holdings, Inc. Arcturus Therapeutics Holdings Inc. Call Options Transaction History
Sumitomo Mitsui Trust Holdings, Inc.
- $156 Billion
- Q2 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding ARCT
# of Institutions
171Shares Held
25.9MCall Options Held
321KPut Options Held
136K-
Federated Hermes, Inc. Pittsburgh, PA4.69MShares$103 Million0.12% of portfolio
-
Black Rock Inc. New York, NY2.65MShares$58 Million0.0% of portfolio
-
Nikko Asset Management Americas, Inc.1.83MShares$40 Million0.25% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.81MShares$39.6 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl1.72MShares$37.5 Million0.18% of portfolio
About Arcturus Therapeutics Holdings Inc.
- Ticker ARCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 26,576,400
- Market Cap $581M
- Description
- Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The company's development programs comprise LUNAR-OTC development program for ornithine transcarbamylase (OTC) deficiency; and LUNAR-CF program for cystic fibrosis lun...